Bleeding Clinical Trials

190 recruitingLast updated: June 17, 2026

There are 190 actively recruiting bleeding clinical trials across 51 countries. Studies span Not Applicable, Phase 3, Phase 4, Phase 2, Phase 1, Early Phase 1. Top locations include Boston, Massachusetts, United States, New York, New York, United States, Montreal, Quebec, Canada. Updated daily from ClinicalTrials.gov.


Bleeding Trials at a Glance

190 actively recruiting trials for bleeding are listed on ClinicalTrialsFinder across 6 cities in 51 countries. The largest study group is Not Applicable with 69 trials, with the heaviest enrollment activity in Boston, New York, and Montreal. Lead sponsors running bleeding studies include Chinese University of Hong Kong, Assiut University, and Helsinki University Central Hospital.

Treatments under study

About Bleeding Clinical Trials

Looking for clinical trials for Bleeding? There are currently 41 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Bleeding trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Bleeding clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 190 trials

Recruiting

A Study of a Urine Test to Detect Colorectal Cancer

Rectal bleedingColorectal, CancerCRC+1 more
Memorial Sloan Kettering Cancer Center210 enrolled4 locationsNCT07649057
Recruiting

Prospective HemorrhoIdaL EmboliSation (PILES) Registry

Hemorrhoid BleedingHemorrhoidInternal Hemorrhoids+2 more
Joint & Vascular Institute1,200 enrolled1 locationNCT07635784
Recruiting
Phase 4

Enhancement of the Haemostatic Effect of Platelets in the Presence of High Normal Concentrations of Von Willebrand Factor

Bleeding
University Hospital, Basel, Switzerland120 enrolled1 locationNCT04555785
Recruiting
Not Applicable

COmbined pLaTelet and eRythrocyte AutotransfusioN During Cardiac surgEry (COLTRANE) Trial

On-pump Cardiac SurgeryHigh Risk for BleedingAutotransfusion
University Hospital, Bordeaux570 enrolled10 locationsNCT06425614
Recruiting
Not Applicable

Comparison of Underdilated Versus Standard TIPS in Preventing Variceal Rebleeding in Patients With Cirrhosis

Liver CirrhosisGastroesophageal Varices Bleeding
Air Force Military Medical University, China648 enrolled1 locationNCT07253389
Recruiting

Assessment of Female Sexual Function Index (FSFI) Scores at 1 Month After Endometrial Sampling Performed Under Sedo-Analgesia or Local Anesthesia

Female Sexual DysfunctionEndometrial SamplingFemale Sexual Function Index (FSFI)+1 more
Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization210 enrolled1 locationNCT07628660
Recruiting

Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy

Ovarian CancerCervical CancerEndometrial Cancer+5 more
Aesculap AG132 enrolled2 locationsNCT06024109
Recruiting
Not Applicable

Delivering tAN to Reduce HMB: The LUNA Study

Heavy Menstrual Bleeding
Spark Biomedical, Inc.80 enrolled1 locationNCT07326722
Recruiting
Phase 2

Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery

BleedingColorectal DisordersThromboembolism+1 more
Kristen Ban394 enrolled1 locationNCT06657924
Recruiting

Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All Case Investigation)

Factor Xa InhibitorLife Threatening Bleeding
AstraZeneca300 enrolled65 locationsNCT05454787
Recruiting
Phase 3

Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial

SurgeryChronic Kidney DiseasesAcute Kidney Injury+1 more
Hamilton Health Sciences Corporation100 enrolled3 locationsNCT06337838
Recruiting
Phase 4

Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism

Cardiovascular DiseasesVenous ThromboembolismPulmonary Embolism+6 more
Drahomir Aujesky276 enrolled40 locationsNCT04263038
Recruiting
Not Applicable

Timing of Anticoagulant Administration During Radial Access Percutaneous Coronary Intervention: the HERA-PCI Study (Heparin Early for Radial Access Percutaneous Coronary Intervention)

BleedingPercutaneous Coronary InterventionCoronary Angiography+2 more
University Hospital, Strasbourg, France550 enrolled1 locationNCT06890312
Recruiting
Not Applicable

How Bleeding Affects Delirium in Older Patients With Hip Fractures: The IMPROVE-HIP Study

BleedingDelirium - PostoperativeHip Fracture
University of Aarhus198 enrolled2 locationsNCT06938789
Recruiting

Ex Vivo Reproduction of Minimally Invasive Surgery With Hematoma Lysis Using Modified Tissue Plasminogen Activator for Intracerebral Hemorrhage

Bleeding DisordersIntracerebral HemorrhageHemorrhagic Risk Conditions
University Hospital, Lille1,126 enrolled1 locationNCT07411079
Recruiting

Evaluation of DNA Methylation Markers for Endometrial Cancer Risk-stratification Using Patient-collected Urine and Vaginal Samples and Clinician-collected Cervical Samples From Women With Postmenopausal Bleeding

Postmenopausal Bleeding
University of Aarhus600 enrolled3 locationsNCT07400835
Recruiting

Hormonal Management of Heavy Menstrual Bleeding in Adolescents

Bleeding DisorderHeavy Menstrual Bleeding
University Hospital, Geneva163 enrolled1 locationNCT06740929
Recruiting
Not Applicable

Rectal Arterial Embolization vs Band Ligation for the Treatment of Internal hemOrrhoidS

HAEHemorrhoids, InternalHemorrhoidal Bleeding+1 more
Jessica K. Stewart, MD40 enrolled1 locationNCT07559630
Recruiting
Not Applicable

Videos to Aid Decision Making for Fibroid Treatment

Decision AidUterine Bleeding
University of Pennsylvania154 enrolled1 locationNCT07072364
Recruiting
Not Applicable

Evaluation of a Toothpaste Containing a Gum Health Active in Participants With Gingival Problem

Gingival bleedingGingival inflammationDental Plaque
Unilever R&D150 enrolled1 locationNCT07415733